B3GALT9

Chr 9

beta-1,3-galactosyltransferase 9

Also known as: B3GNT10

The protein is a putative glycosyltransferase that transfers galactose residues from UDP-alpha-D-galactose and is involved in protein O-linked glycosylation in the Golgi apparatus. Based on the provided information, no specific diseases, inheritance patterns, or pathogenic mechanisms have been established for B3GALT9 mutations.

OMIMResearchSummary from RefSeq, UniProt
DNmechanism

Population Genetics & Constraint

Constraint data not available from gnomAD.

DN
0.6161th %ile
GOF
0.6247th %ile
LOF
0.2092th %ile

The Badonyi & Marsh model scores gain-of-function highest, but genomic evidence most strongly supports dominant-negative as the primary mechanism.

DNprediction above median

Note: In-silico variant effect predictors (SIFT, PolyPhen, REVEL, CADD) may underestimate pathogenicity of missense variants in genes with GOF or DN mechanisms. Consider functional evidence and clinical context.

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312.

ClinVar Variant Classifications

0 submitted variants in ClinVar

Protein Context — Lollipop Plot

B3GALT9 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

3D Protein StructureAlphaFold

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →
Clinical Literature
Open Research Assistant →
Full-Text Mentions
NLP-detected gene mentions in article bodies · via PubTator3
PubTator3
Top 2 full-text resultsSearch PubTator3 ↗
Recent Gene-Specific Literature
Gene in title · MEDLINE · newest first
Europe PMC

No open access results found